home Drug Discov Today Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.

Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.

Icon for Elsevier Science Related Articles

Cancer cell fusion: a potential target to tackle drug-resistant and metastatic cancer cells.

Drug Discov Today. 2019 Jun 01;:

Authors: Fernandes C, Prabhu P, Juvale K, Suares D, Yc M

Abstract
Cell fusion is an integral, established phenomenon underlying various physiological processes in the cell cycle. Although research in cancer metastasis has hypothesised numerous molecular mechanisms and signalling pathways responsible for invasion and metastasis, the origin and progression of metastatic cells within primary tumours remains unclear. Recently, the role of cancer cell fusion in cancer metastasis and development of multidrug resistance (MDR) in tumours has gained prominence. However, evidence remains lacking to justify the role of cell fusion in cancer metastasis and drug resistance. Here, we highlight plausible mechanisms governing cell fusion with different cell types in the tumour microenvironment (TME), the clinical relevance of cancer cell fusion, its potential as a target for overcoming MDR and inhibiting metastasis, and putative modes of treatment.

PMID: 31163272 [PubMed - as supplied by publisher]